These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38262735)

  • 1. Factors associated with the use of psychedelics, ketamine and MDMA among sexual and gender minority youths in Canada: a machine learning analysis.
    Dharma C; Liu E; Grace D; Logie C; Abramovich A; Mitsakakis N; Baskerville B; Chaiton M
    J Epidemiol Community Health; 2024 Mar; 78(4):248-254. PubMed ID: 38262735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics and reconsolidation of traumatic and appetitive maladaptive memories: focus on cannabinoids and ketamine.
    Fattore L; Piva A; Zanda MT; Fumagalli G; Chiamulera C
    Psychopharmacology (Berl); 2018 Feb; 235(2):433-445. PubMed ID: 29178010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of psychedelics in the Czech Republic: results of recent population surveys.
    Chomynová P; Kočárová R; Kňažek F; Plevková M; Bláhová B; Valeš K; Mravčík V
    Cent Eur J Public Health; 2022 Sep; 30(3):144-153. PubMed ID: 36239361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular MDMA use is associated with decreased risk of drug injection among street-involved youth who use illicit drugs.
    Gaddis A; Lake S; Tupper K; Nosova E; Blommaert K; Wood E; DeBeck K
    Drug Alcohol Depend; 2018 Nov; 192():112-117. PubMed ID: 30245459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intimate Partner Violence and Illicit Substance Use Among Sexual and Gender Minority Youth: The Protective Role of Cognitive Reappraisal.
    Scheer JR; Mereish EH
    J Interpers Violence; 2021 Nov; 36(21-22):9956-9976. PubMed ID: 31608738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
    Lyvers M; Meester M
    J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recreational use of psychedelics is associated with elevated personality trait openness: Exploration of associations with brain serotonin markers.
    Erritzoe D; Smith J; Fisher PM; Carhart-Harris R; Frokjaer VG; Knudsen GM
    J Psychopharmacol; 2019 Sep; 33(9):1068-1075. PubMed ID: 30816797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Mental Health across Distinct Groups of Users of Psychedelics, MDMA, Psychostimulants, and Cannabis.
    Rougemont-Bücking A; Jungaberle H; Scheidegger M; Merlo MCG; Grazioli VS; Daeppen JB; Gmel G; Studer J
    J Psychoactive Drugs; 2019; 51(3):236-246. PubMed ID: 30836844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders.
    Lowe H; Toyang N; Steele B; Grant J; Ali A; Gordon L; Ngwa W
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addiction specialists' attitudes toward psychedelics: A National Survey.
    Kim A; Suzuki J
    Am J Addict; 2023 Nov; 32(6):606-609. PubMed ID: 37550848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and abuse of dissociative and psychedelic drugs in adolescence.
    Bates MLS; Trujillo KA
    Pharmacol Biochem Behav; 2021 Apr; 203():173129. PubMed ID: 33515586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in long-term relapse rates between youths with ketamine use and those with stimulants use.
    Wang LJ; Chen MY; Lin CY; Chong MY; Chou WJ; You YH; Tsai CP; Chen YS; Lu SF
    Subst Abuse Treat Prev Policy; 2018 Dec; 13(1):50. PubMed ID: 30577882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in drug use among electronic dance music party attendees in New York City, 2016-2019.
    Palamar JJ; Keyes KM
    Drug Alcohol Depend; 2020 Apr; 209():107889. PubMed ID: 32050110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Psychedelics in Treatment-Resistant Depression.
    Kamal S; Jha MK; Radhakrishnan R
    Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).
    Ho E; Karimi-Tabesh L; Koren G
    Neurotoxicol Teratol; 2001; 23(6):561-7. PubMed ID: 11792525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent trends in the use of "club drugs": an Australian review.
    Degenhardt L; Copeland J; Dillon P
    Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-risk drug use: epidemiological pattern through hair testing in the forensic context].
    Burgueño MJ; Sánchez S; Castro MÁ; Mateos-Campos R
    Rev Esp Salud Publica; 2019 Nov; 93():. PubMed ID: 31767827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurotrophic mechanisms of psychedelic therapy].
    Corne R; Mongeau R
    Biol Aujourdhui; 2019; 213(3-4):121-129. PubMed ID: 31829932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):46-56. PubMed ID: 34983249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.
    Jones GM
    J Psychopharmacol; 2023 Jan; 37(1):61-69. PubMed ID: 36314881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.